The study authors said the results could lead to an update in how the lung conditions are managed. View on euronews ...
The results demonstrate the safety and efficacy of Fasenra in the treatment of acute eosinophilic exacerbations in asthma and ...
Researchers have discovered the first major treatment for asthma attacks in 50 years using a drug called Benralizumab.
It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...
Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the ...
The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...
AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that ...
A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and ...
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...
A clinical trial of the drug benralizumab showed it was far more effective than conventional steroid tablets at treating life-threatening breathing difficulties in people with a severe form of the ...